TY - JOUR
T1 - THE EFFECT OF IVERMECTIN ON SOME HAEMATOLOGICAL INDICES IN RABBITS
T2 - INFLUENCE OF VITAMIN K TREATMENT
AU - Ali, B. H.
PY - 1990/10
Y1 - 1990/10
N2 - 1. Rabbits were treated with the antiparasitic drug ivermectin at subcutaneous doses of 0.2, 1 and 2.5 mg/kg and blood collected weekly for 4 weeks thereafter for measuring some blood parameters. At a dose of 0.2 or 1 mg/kg the drug had no significant effect on any of the parameters measured. At a dose of 2.5 mg/kg, the drug reduced significantly the erythrocyte counts, haemoglobin concentration, haematocrit, mean corpuscular haemoglobin concentration and mean corpuscular haemoglobin on weeks 1, 2, 3 and 4. Platelet counts were not significantly affected. 2. In another trial, ivermectin was injected subcutaneously at a dose of 2.5 mg/kg, after pre‐treatment with either saline or vitamin K (30 μg/kg for 30 days), and prothrombin time, bleeding time and platelet counts measured at weekly intervals for 4 weeks. Bleeding time and thrombin time were significantly increased 1 week after treatment, and remained higher than the control for 4 weeks.
AB - 1. Rabbits were treated with the antiparasitic drug ivermectin at subcutaneous doses of 0.2, 1 and 2.5 mg/kg and blood collected weekly for 4 weeks thereafter for measuring some blood parameters. At a dose of 0.2 or 1 mg/kg the drug had no significant effect on any of the parameters measured. At a dose of 2.5 mg/kg, the drug reduced significantly the erythrocyte counts, haemoglobin concentration, haematocrit, mean corpuscular haemoglobin concentration and mean corpuscular haemoglobin on weeks 1, 2, 3 and 4. Platelet counts were not significantly affected. 2. In another trial, ivermectin was injected subcutaneously at a dose of 2.5 mg/kg, after pre‐treatment with either saline or vitamin K (30 μg/kg for 30 days), and prothrombin time, bleeding time and platelet counts measured at weekly intervals for 4 weeks. Bleeding time and thrombin time were significantly increased 1 week after treatment, and remained higher than the control for 4 weeks.
UR - http://www.scopus.com/inward/record.url?scp=0025241655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025241655&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1681.1990.tb01273.x
DO - 10.1111/j.1440-1681.1990.tb01273.x
M3 - Article
C2 - 2272130
AN - SCOPUS:0025241655
SN - 0305-1870
VL - 17
SP - 735
EP - 738
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
IS - 10
ER -